GlobeImmune
Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Learn more
Launch date
Employees
Market cap
AUD3.1m
Enterprise valuation
(AUD10m) (Public information from Sep 2024)
Share price
$0.0002 GBIM
Louisville Kentucky (HQ)
Authorizing premium user...